Best Peptides for Skin

The top peptides for skin in South Africa in 2026 are GHK-Cu, BPC-157, and TB-500, available as pre-mixed research blends that combine collagen-stimulating, wound-repair, and tissue-regeneration mechanisms in a single vial.

This article covers how these three peptides work at the cellular level, which format (pre-mixed pen or powder) suits your research protocol, current South African pricing and availability, and how to match specific peptides to skin concerns such as acne, scarring, and ageing.

Top skin peptides to know:

• GHK-Cu, copper tripeptide that upregulates extracellular matrix remodelling and collagen-related gene expression at concentrations as low as 1–10 nM in preclinical assay models
• BPC-157, body protection compound studied in preclinical murine models for accelerated wound closure and angiogenesis at doses of 150–375 µg
• TB-500, thymosin beta-4 fragment associated with cytoskeletal dynamics and tissue repair in preclinical models
• Pre-mixed "Glow" blends, single lyophilised vials combining all three (typically 10 mg BPC-157, 50 mg GHK-Cu, 10 mg TB-500) that remove the need for separate reconstitution

All three remain investigational substances without approved human clinical data as of 2026. South African researchers should verify current SAHPRA (South African Health Products Regulatory Authority) status before sourcing, as local regulatory guidance is not publicly confirmed for this period.

Why Peptides Matter for Skin Health

Peptides are short chains of amino acids that act as signalling molecules, instructing skin cells to produce collagen, elastin, and other structural proteins rather than supplying those proteins directly. This distinction matters: a peptide does not patch damaged tissue; it triggers the cellular machinery that does.

How Peptides Signal Collagen Production

Collagen synthesis declines measurably from the mid-twenties onward, and the skin's repair response slows with it. Peptides intervene at the signalling level. GHK-Cu, for example, upregulates extracellular matrix remodelling and collagen-related gene expression at concentrations as low as 1–10 nM in preclinical in-vitro assay models. That is a nanomolar threshold, the molecule exerts biological effect at trace concentrations rather than through bulk supplementation.

BPC-157 operates through a separate pathway, with preclinical murine models showing accelerated wound closure and angiogenesis at doses of 150–375 µg. TB-500, a thymosin beta-4 fragment, is associated with cytoskeletal dynamics and tissue repair in preclinical models. Together, these three mechanisms cover collagen upregulation, vascular repair, and cellular scaffolding. Pre-mixed research blends combining all three have gained traction among researchers exploring skin regeneration protocols.

Research-Stage Status

None of these peptides carry approved human clinical data as of 2026. The mechanistic data cited above are largely pre-2023 and derived from animal or in-vitro models, so translating preclinical findings directly to expected human outcomes is not supported by current evidence. In South Africa, SAHPRA has not publicly confirmed a regulatory classification for GHK-Cu, BPC-157, or TB-500, and practitioners generally treat them as unregistered research substances. Researchers sourcing these compounds should verify current SAHPRA guidance independently before proceeding.

For those whose interest extends beyond skin-specific applications, the best peptides for longevity covers compounds such as Epithalon that may support skin health indirectly through systemic anti-ageing pathways. A broader overview of cosmetic and topical applications is available in the best peptides for beauty guide.

GHK-Cu: The Copper Tripeptide for Collagen Regeneration

GHK-Cu (glycine-histidine-lysine copper complex) is a naturally occurring tripeptide that stimulates fibroblast production of collagen types I, III, and IV, promotes extracellular matrix remodelling, and supports wound healing through upregulation of collagen-related gene expression. It is the most mechanistically documented skin peptide in current research use.

How the Mechanism Works

GHK-Cu binds copper ions and delivers them directly to fibroblasts, where the complex activates collagen synthesis pathways at concentrations as low as 1–10 nM in in-vitro assay systems. The result is increased production of structural collagens alongside matrix metalloproteinase regulation, which governs how the skin breaks down and rebuilds its own scaffolding. Pre-2023 fibroblast culture data, the primary evidence base as of 2026, given the absence of confirmed 2024–2026 peer-reviewed human trials, showed collagen upregulation of up to 300% under GHK-Cu stimulation. These findings are derived from animal and in-vitro models and should not be read as guaranteed human outcomes.

Evidence Status in 2026

The mechanistic picture for GHK-Cu is well-established at the preclinical level, but controlled human clinical data from 2023 to 2026 could not be confirmed in available sources. Researchers should treat the collagen-synthesis figures as directional rather than definitive. GHK-Cu is an unregistered research substance in South Africa; SAHPRA has not publicly issued a specific classification, and practitioners generally handle it under research-use frameworks.

South African Availability and Pricing

Pre-mixed blends combining GHK-Cu with BPC-157 and TB-500 are the most accessible format for South African researchers. The "Glow"-type 70 mg vials (typically 50 mg GHK-Cu, 10 mg BPC-157, 10 mg TB-500) are available from international suppliers at USD 52–99 per vial as of 2024. JCSG-specific ZAR pricing for 2026 could not be independently verified from available sources and should be confirmed directly on the JCSG catalogue before ordering.

Pre-mixed lyophilised vials remove the need to source bacteriostatic water, calculate dilutions, and manage separate powder vials, a practical advantage for researchers running multi-week protocols.

Typical Research Protocol and Safety Profile

Key parameters drawn from vendor and preclinical literature:

• Dose range: 1–2 mg per administration, applied 3–5 times weekly in most research frameworks
• Protocol duration: 14–30 days per research run, with the reconstituted vial used across that window
• Local tolerability: injection-site irritation is the most commonly noted adverse event in informal reports; no robust 2023–2026 human safety dossier exists for GHK-Cu
• Combination use: GHK-Cu is frequently paired with BPC-157 and TB-500 to address collagen upregulation, angiogenesis, and cytoskeletal repair simultaneously within a single vial

Researchers whose protocols extend to systemic anti-ageing alongside skin regeneration may find the best peptides for longevity guide relevant, particularly for compounds such as Epithalon that may support skin health through broader cellular pathways. Topical and cosmetic peptide applications are covered separately in the best peptides for beauty guide.

BPC-157 & TB-500 Combined: Synergistic Wound Healing & Tissue Repair

BPC-157 and TB-500 are the two most frequently co-administered peptides in skin repair and post-procedure recovery protocols, each targeting distinct but complementary biological pathways.

What each peptide does in the combination:

• BPC-157 promotes angiogenesis by upregulating VEGF (vascular endothelial growth factor) signalling, reduces local inflammatory mediators, and accelerates wound closure in preclinical murine models. Mechanistic data are pre-2023 and animal-derived, yet continue to underpin current research frameworks
• TB-500 (thymosin beta-4 fragment) modulates actin polymerisation to increase cell migration, attenuates inflammatory cytokine activity, and supports extracellular matrix remodelling in preclinical tissue-repair models
• Combined effect: the angiogenic drive from BPC-157 pairs with TB-500's cell-migration support to address both vascular supply and structural repair simultaneously. Vendors formulate them into a single vial rather than selling them as separate protocols
• Skin-specific relevance: post-procedure recovery, collagen matrix restoration, and reduction of repair downtime are the primary research applications cited in available vendor literature

Mechanism Transparency

No 2024–2026 peer-reviewed human clinical trials specifically measuring wound closure rates or inflammatory marker reduction for this combination in human skin could be confirmed from available sources. Mechanistic claims rest on pre-2023 preclinical data and should be read as investigational rather than clinically validated.

South African Availability and Pricing

Pre-mixed lyophilised vials containing BPC-157, TB-500, and GHK-Cu in a single 70 mg blend are available from international research suppliers at USD 52–99 per vial (2024 pricing). JCSG-specific ZAR pricing for 2026 could not be independently verified and should be confirmed directly on the JCSG catalogue before ordering.

Typical Research Protocol

Most research frameworks use 2–5 mg of each peptide per administration, dosed three to five times weekly over a 14–30 day run. The lyophilised vial format covers a full multi-week protocol after a single reconstitution, removing the need to manage separate powder vials for each compound.

Researchers extending their focus to broader anti-ageing outcomes alongside skin repair may find the best peptides for longevity guide useful, particularly for compounds that may support skin health through systemic cellular pathways. Topical and cosmetic applications are covered in the best peptides for beauty guide.

Melanotan II: Melanin Production & Skin Pigmentation

Melanotan II is a synthetic analogue of alpha-melanocyte-stimulating hormone that activates the melanocortin-1 receptor (MC1R), triggering increased melanin synthesis in melanocytes. As an MC1R agonist, it is the peptide most directly studied for pigmentation, tanning response, and photoprotection research.

How It Works

MC1R activation shifts melanocyte output toward eumelanin, the darker, UV-protective form of melanin. This mechanism differs from UV-induced tanning because it does not require sun exposure to initiate pigment production. Preclinical and early human observational data suggest pigmentation changes can appear within 3–7 days of protocol initiation, though these timelines are drawn from anecdotal practitioner ranges and have not been confirmed in 2023–2026 controlled human trials.

Research Applications

Melanotan II attracts investigational interest across four overlapping areas:

• Pigmentation modelling, studying how MC1R agonism alters skin tone in different Fitzpatrick phototypes
• Photoprotection research, exploring whether elevated baseline melanin reduces UV-induced DNA damage markers
• Hypopigmentation models, investigating potential relevance to conditions characterised by localised melanin deficiency
• Tanning response studies, quantifying dose-response relationships between peptide concentration and measurable colorimetric skin change

South African researchers working with diverse Fitzpatrick phototypes have a practical context for pigmentation studies that differs from predominantly lighter-skinned research cohorts used in older European literature.

Side Effects and Titration

The most consistently reported adverse effects in observational literature are nausea, facial flushing, and transient increases in libido. Slow titration, starting at 0.25 mg and increasing to 0.5–1 mg per administration over one to two weeks, is the standard approach used in research frameworks to reduce nausea incidence. Darkening of existing nevi has also been noted in informal reports; this warrants monitoring in any research context. No 2023–2026 peer-reviewed human safety dossier for Melanotan II could be confirmed from available sources.

South African Availability and Regulatory Note

JCSG stocks Melanotan II for research purposes; confirm current ZAR pricing directly on the JCSG catalogue, as 2026 pricing could not be independently verified. SAHPRA's current classification of Melanotan II should be checked before ordering, as South African regulatory status for unregistered peptides remains unverified against 2024–2026 published guidance.

Researchers combining pigmentation work with broader skin health protocols may find the best peptides for beauty guide relevant, particularly for compounds addressing skin tone and texture alongside melanin dynamics.

Pre-Mixed Peptide Pens vs. Powder: Which Format to Choose

Pre-mixed peptide pens remove reconstitution entirely, making them the lower-friction option for researchers who prioritise consistency over cost. The trade-off is real: convenience carries a price premium, and understanding where that premium goes helps you decide which format suits your protocol.

What Pre-Mixed Pens Offer

• Ready to administer, no bacteriostatic water, no sterile mixing equipment required
• Consistent dosing per actuation, reducing measurement error
• Reduced contamination risk (JCSG user feedback, 2026, estimates approximately 95% lower contamination incidence versus manual reconstitution)
• Shorter shelf life, typically 6–12 months from manufacture
• Higher upfront cost: JCSG's pre-mixed GHK-Cu pen is listed at approximately R1,760 (2026 pricing, confirm current figure directly with JCSG, as catalogue prices are subject to change)

What Powder Reconstitution Offers

• Lower acquisition cost: an equivalent GHK-Cu powder vial is estimated at R800–R1,200 before reconstitution consumables (2026 estimate)
• Longer shelf life, lyophilised powder stored correctly at –20 °C can remain stable for 2–3 years
• Greater flexibility in concentration and volume for research protocols
• Requires bacteriostatic water, sterile syringes, and consistent aseptic technique, adding 10–15 minutes per preparation session

Format Comparison at a Glance

Pre-mixed pens cost more per dose but remove preparation time and contamination variables that matter in multi-week skin research protocols.

Factor	Pre-Mixed Pen	Lyophilised Powder
Preparation time	~0 min	10–15 min per session
Estimated cost (GHK-Cu, 2026)	~R1,760	R800–R1,200 + consumables
Shelf life	6–12 months	2–3 years (stored at –20 °C)
Contamination risk	Low	Higher without strict aseptic technique
Dosing consistency	Fixed per actuation	Dependent on researcher accuracy

For researchers running short, defined protocols, four to eight weeks on a collagen-support stack, for example, the pen format's consistency and time saving often justify the cost difference. Longer-term or higher-volume research programmes where cost per dose accumulates over months tend to favour powder, provided the researcher has reliable sterile technique and cold-storage capacity.

Researchers exploring peptides beyond skin repair may find the best peptides for longevity guide useful, particularly for compounds like Epithalon that intersect with anti-ageing skin outcomes. Those focused on broader aesthetic applications can cross-reference the best peptides for beauty guide for context on how skin-tone and texture peptides sit alongside the formats discussed here.

South African Peptide Pricing & Availability 2026

Pricing for skin-focused peptides at JCSG varies by format and compound, with pre-mixed pens carrying a premium over lyophilised powder but removing reconstitution variables. All figures below are estimates current to mid-2026 and subject to stock availability.

2026 Pricing Overview

• GHK-Cu 50 mg pre-mixed pen, R1,760; at a typical 1 mg daily research dose, pen lifespan determines monthly cost, estimated at R1,100–R1,400 per month
• BPC-157 & TB-500 combination pen (32-dose), R2,640; monthly cost depends on dosing frequency within the protocol
• GHK-Cu / BPC-157 / TB-500 blend (70 mg lyophilised vial), international supplier pricing ranges from USD 52–99 per vial; ZAR equivalent at JCSG is and will reflect local import duties and mark-up
• Melanotan II, pricing at JCSG is for 2026; availability should be confirmed directly with the supplier given its distinct regulatory profile
• Epithalon, stocked by some South African suppliers as a longevity-adjacent compound; ZAR pricing is and cross-references with the best peptides for longevity guide for protocol context

Format and Cost Summary

Peptide	Format	Estimated ZAR Price	Typical Monthly Cost
GHK-Cu 50 mg	Pre-mixed pen	R1,760	R1,100–R1,400
BPC-157 & TB-500 combo	Pre-mixed pen (32-dose)	R2,640	Protocol-dependent
GHK-Cu / BPC-157 / TB-500 blend	Lyophilised vial (70 mg)		Lower per-dose; add consumable costs
Melanotan II	Lyophilised vial
Epithalon	Lyophilised vial

GHK-Cu is a copper-binding tripeptide that upregulates collagen and glycosaminoglycan synthesis in preclinical models. Researchers running four-to-eight-week skin protocols should confirm current stock and pricing directly with JCSG before committing to a format, as availability fluctuates. Those exploring skin-tone and texture outcomes alongside collagen support can cross-reference the best peptides for beauty guide for additional compound context.

How to Use Skin Peptides Safely: Dosing & Protocol Basics

Subcutaneous injection is the most common administration route for skin-focused peptides such as GHK-Cu, BPC-157, and TB-500, with intradermal delivery used by some researchers targeting localised dermal remodelling. Getting the basics right before starting any protocol reduces risk and improves the consistency of results.

Administration Routes

GHK-Cu is typically administered subcutaneously into the abdominal or thigh tissue. BPC-157 and TB-500 follow the same route in most research protocols, though some practitioners use intramuscular injection for TB-500 given its systemic tissue-repair mechanism. Intradermal administration is less common and requires finer-gauge needles and precise technique.

Starting Doses and Titration

A conservative starting dose of 0.5–1 mg per administration allows the researcher to assess individual response before increasing. Titration over one to two weeks to a target dose is standard practice. Typical research ranges cited in vendor documentation are:

• GHK-Cu, 1–2 mg per administration, daily or three to five times weekly
• BPC-157, 2–5 mg per administration, three to five times weekly
• TB-500, 2–5 mg per administration, three to five times weekly

These figures come from vendor-supplied research protocols rather than controlled human clinical trials, so they carry status for human dosing purposes.

Storage and Sterile Technique

Lyophilised vials should be stored in a cool, dark environment before reconstitution; once reconstituted with bacteriostatic water, refrigerate at 2–8 °C and use within 28–30 days. Pre-mixed formulations follow the same cold-chain requirement. Each injection requires a fresh sterile needle, an alcohol swab on the injection site, and careful aspiration technique to avoid introducing contaminants.

Expected Timelines

Vendor mechanistic descriptions for GHK-Cu/BPC-157/TB-500 blends frame outcomes in terms of extracellular matrix remodelling and angiogenesis rather than specific human timelines. Practitioner-reported ranges, four to eight weeks for collagen-related changes such as improved skin firmness and hydration with GHK-Cu, and one to two weeks for wound-healing acceleration with BPC-157, are anecdotal and against 2024–2026 controlled human data. No peer-reviewed human studies confirming these timelines were identified in the current source set.

Researchers combining skin peptides with broader anti-ageing goals can cross-reference the best peptides for longevity guide for Epithalon protocol context, and the best peptides for beauty guide for compounds targeting skin tone and texture alongside collagen support.

Peptides for Specific Skin Concerns: Acne, Scarring & Ageing

Not every skin peptide suits every concern. Matching the right compound to the underlying mechanism, inflammation, collagen deficit, cellular senescence, or pigmentation imbalance, determines whether a protocol produces measurable change or simply adds cost.

Acne and Active Inflammation

BPC-157 is the primary candidate for acne-prone skin, with preclinical models showing suppression of pro-inflammatory cytokines and modulation of nitric oxide pathways that contribute to sebaceous gland overactivity. TB-500 complements this by regulating actin-driven immune cell migration, which may reduce the localised immune overreaction that drives cystic lesions. Both remain investigational; no 2024–2026 controlled human trials on acne endpoints were identified in the current source set, so these mechanistic rationales carry status for clinical application.

Scarring and Tissue Remodelling

GHK-Cu is the most mechanistically supported peptide for scarring. In-vitro fibroblast assays (largely pre-2023 and therefore tagged) report collagen type I and III upregulation in the range of 200–300% at nanomolar concentrations. BPC-157 adds an angiogenic dimension: preclinical wound models show accelerated capillary formation at repair sites, which is relevant for atrophic acne scars where poor vascularisation slows remodelling. A blended vial containing 50 mg GHK-Cu, 10 mg BPC-157, and 10 mg TB-500 addresses all three remodelling pathways simultaneously.

Anti-Ageing and Cellular Renewal

GHK-Cu drives extracellular matrix synthesis and has been shown in preclinical models to upregulate genes associated with skin repair and barrier integrity. Epithalon operates at a different level: it activates telomerase, the enzyme that extends telomere length in ageing cells, positioning it as a cellular renewal compound rather than a structural one. Researchers pursuing longevity-oriented skin protocols can find Epithalon dosing context in the best peptides for longevity guide.

Hyperpigmentation

GHK-Cu supports skin barrier repair and may indirectly normalise uneven pigmentation by reducing oxidative stress in melanocyte-adjacent tissue. Melanotan II stimulates melanocortin receptors to increase melanin production, a mechanism that darkens skin broadly rather than targeting localised hyperpigmentation. Researchers exploring peptides for skin tone and texture alongside these options can cross-reference the best peptides for beauty guide for a fuller compound comparison.

Research Status & Regulatory Clarity in South Africa

GHK-Cu, BPC-157, TB-500, and Melanotan II are not registered medicines in South Africa and are supplied strictly as research chemicals. No SAHPRA approval exists for any of these peptides as of 2026, and specific SAHPRA guidance on their classification remains unverified in current public documentation. Practitioners who use them clinically typically do so under Section 21 exemptions or analogous unregistered medicine provisions, though this is an inference from general regulatory practice rather than confirmed 2026 policy.

What the 2026 FDA Changes Mean for South African Researchers

In April 2026, the FDA removed BPC-157, TB-500, and GHK-Cu from its Category 2 enforcement priority list in the United States. This reduces compounding risk for US pharmacies but does not constitute approval, and it carries no direct legal weight in South Africa. The change may influence global supply chains and practitioner sentiment locally, but South African researchers should verify current SAHPRA status independently before sourcing or administering any of these compounds.

Your Responsibility as a Researcher

All use of these peptides in South Africa is experimental. No claims of medical efficacy are made here, and nothing in this article constitutes medical advice. Consult a registered healthcare provider before use, particularly if you are on chronic medication or managing a pre-existing condition. Researchers interested in broader skin and beauty applications can cross-reference the best peptides for beauty guide, and those pursuing anti-ageing protocols that extend beyond structural skin repair may find relevant context in the best peptides for longevity guide.

Common Questions About Skin Peptides

How long do results last?

Skin peptides produce results that persist only as long as the protocol continues. Collagen synthesis is an ongoing biological process, not a one-time event, so most researchers treat maintenance dosing as standard practice rather than optional. GHK-Cu stimulates extracellular matrix remodelling and collagen-related gene expression through continuous receptor engagement. Once dosing stops, the upstream signal diminishes and collagen turnover returns to baseline. Practitioners typically describe maintenance cycles rather than finite treatment courses, though specific cycle durations remain anecdotal and are not confirmed by 2024–2026 controlled human data.

Can peptides be combined?

Yes. BPC-157 and TB-500 are frequently paired because their mechanisms are complementary: BPC-157 supports tissue repair at the local level while TB-500 (thymosin beta-4 fragment) promotes angiogenesis and cytoskeletal dynamics systemically. GHK-Cu is commonly added to this stack, as seen in the 70 mg research blends (10 mg BPC-157 / 50 mg GHK-Cu / 10 mg TB-500) offered by multiple suppliers. Stacking increases protocol complexity and, where human safety data are already limited, compounds the uncertainty around interactions.

What are the known side effects?

Formal 2023–2026 human adverse-event data for these peptides are not available in peer-reviewed form; the compounds remain investigational. Based on preclinical characterisation and informal practitioner reporting:

• Injection site irritation, localised redness or mild swelling; the most commonly noted reaction across BPC-157, TB-500, and GHK-Cu use
• Nausea and flushing, associated specifically with Melanotan II, alongside appetite changes and darkening of existing nevi
• Allergic reactions, rare; no frequency data confirmed for 2024–2026
• No regulatory-grade human safety dossier exists for any of these peptides as of April 2026

Researchers with pre-existing conditions or chronic medication regimens should consult a registered healthcare provider before use.

How should peptides be stored?

Lyophilised powder vials should be kept in a cool, dark environment away from direct light and humidity. Once reconstituted, store at 2–8 °C and use within the timeframe specified by the supplier, typically 14–30 days. Pre-mixed formulations follow the same refrigeration requirement.

Research-grade vs pharmaceutical-grade: what is the difference?

Research-grade peptides are not approved for human use; they are manufactured for laboratory investigation and carry no regulatory oversight of dosing, sterility standards, or clinical indication. Pharmaceutical-grade compounds are approved by a medicines regulator (such as SAHPRA locally, or the FDA in the United States), manufactured under GMP (Good Manufacturing Practice) conditions, and supported by clinical trial data. None of the peptides covered in this article, BPC-157, TB-500, GHK-Cu, or Melanotan II, hold pharmaceutical-grade approval in South Africa as of 2026.

Researchers exploring adjacent applications can find further context in the best peptides for beauty guide, and those considering broader anti-ageing protocols may find relevant framing in the best peptides for longevity guide.

Where to Buy Peptides in South Africa: JCSG & Alternatives

For South African researchers, JCSG is the most accessible verified local supplier, offering pre-mixed peptide formulations, transparent product pages, and domestic shipping that avoids the import delays and customs uncertainty common with international orders.

JCSG

JCSG stocks both raw lyophilised vials and pre-mixed options across several peptide categories. Their Melanotan II product page lists the compound with a clear research-only disclaimer, the baseline transparency standard any reputable supplier should meet. JCSG also carries Body Pharm-branded products, including Body Pharm Selank 10 and CJC-1295 with Ipamorelin, giving researchers access to a secondary manufacturer's quality standards within the same order.

Evaluating Any Supplier

Before purchasing from any source, check for the following:

• Third-party certificate of analysis (CoA) from an independent laboratory, with batch numbers that match the vial label
• A physical contact address and verifiable business registration, not just a contact form
• Explicit research-only or not-for-human-use disclaimers on every product page
• Clear storage and handling guidance published alongside the product, not buried in a PDF

Suppliers without CoA documentation or with no traceable contact information carry meaningful quality risk. Peptide purity varies significantly between manufacturers, and without independent testing data there is no reliable way to confirm concentration or sterility.

International Alternatives

International suppliers such as NeuroPept Labs and Biotech Peptides stock GHK-Cu/BPC-157/TB-500 blends, but ordering from outside South Africa introduces rand-denominated exchange rate exposure, import duty liability, and potential SAHPRA classification questions at the border. For most South African researchers, a locally stocked supplier with transparent documentation is the lower-friction starting point.

Researchers focused on skin-specific applications can find complementary product context in the best peptides for beauty guide, while those building broader anti-ageing protocols may find relevant framing in the best peptides for longevity guide.

Key Takeaways

• GHK-Cu, BPC-157, and TB-500 are the three most researched skin peptides in South Africa; all remain investigational with no approved human clinical data as of 2026
• GHK-Cu upregulates collagen synthesis at nanomolar concentrations; BPC-157 and TB-500 address angiogenesis and tissue repair, respectively
• Pre-mixed pens cost more (approximately R1,760 for GHK-Cu) but remove reconstitution risk; lyophilised powder is cheaper but requires sterile technique
• Match peptides to specific concerns: GHK-Cu for scarring and anti-ageing, BPC-157 for inflammation and wound healing, Melanotan II for pigmentation
• Verify current SAHPRA status and source from transparent suppliers with third-party certificates of analysis before ordering
• All use is experimental; consult a registered healthcare provider before starting any protocol

Next Steps

Confirm current JCSG pricing and stock availability directly on the JCSG catalogue for the peptide and format that matches your research protocol. If you are new to peptide administration, start with a pre-mixed pen format to reduce contamination risk and preparation time. Consult a registered healthcare provider before use, particularly if you are on chronic medication or managing a pre-existing skin condition. For broader context on skin-tone and texture applications, cross-reference the best peptides for beauty guide; for anti-ageing protocols extending beyond structural skin repair, see the best peptides for longevity guide.